GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vilacto Bio Inc (GREY:VIBI) » Definitions » Gross Profit

Vilacto Bio (Vilacto Bio) Gross Profit : $0.00 Mil (TTM As of Jun. 2019)


View and export this data going back to 2013. Start your Free Trial

What is Vilacto Bio Gross Profit?

Vilacto Bio's gross profit for the three months ended in Jun. 2019 was $0.00 Mil. Vilacto Bio's gross profit for the trailing twelve months (TTM) ended in Jun. 2019 was $0.00 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Vilacto Bio's gross profit for the three months ended in Jun. 2019 was $0.00 Mil. Vilacto Bio's Revenue for the three months ended in Jun. 2019 was $0.01 Mil. Therefore, Vilacto Bio's Gross Margin % for the quarter that ended in Jun. 2019 was 20.00%.

Vilacto Bio had a gross margin of 20.00% for the quarter that ended in Jun. 2019 => No sustainable competitive advantage


Vilacto Bio Gross Profit Historical Data

The historical data trend for Vilacto Bio's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilacto Bio Gross Profit Chart

Vilacto Bio Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19
Gross Profit
Get a 7-Day Free Trial - - - - -

Vilacto Bio Quarterly Data
Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Vilacto Bio's Gross Profit

For the Biotechnology subindustry, Vilacto Bio's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vilacto Bio's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vilacto Bio's Gross Profit distribution charts can be found below:

* The bar in red indicates where Vilacto Bio's Gross Profit falls into.



Vilacto Bio Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Vilacto Bio's Gross Profit for the fiscal year that ended in Mar. 2019 is calculated as

Gross Profit (A: Mar. 2019 )=Revenue - Cost of Goods Sold
=0.005 - 0.004
=0.00

Vilacto Bio's Gross Profit for the quarter that ended in Jun. 2019 is calculated as

Gross Profit (Q: Jun. 2019 )=Revenue - Cost of Goods Sold
=0.005 - 0.004
=0.00

Gross Profit for the trailing twelve months (TTM) ended in Jun. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Vilacto Bio's Gross Margin % for the quarter that ended in Jun. 2019 is calculated as

Gross Margin % (Q: Jun. 2019 )=Gross Profit (Q: Jun. 2019 ) / Revenue (Q: Jun. 2019 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.00 / 0.005
=20.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Vilacto Bio  (GREY:VIBI) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Vilacto Bio had a gross margin of 20.00% for the quarter that ended in Jun. 2019 => No sustainable competitive advantage


Vilacto Bio Gross Profit Related Terms

Thank you for viewing the detailed overview of Vilacto Bio's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Vilacto Bio (Vilacto Bio) Business Description

Traded in Other Exchanges
N/A
Address
Fabriksvej 48, Suite 2607, The Seagram Building, Naestved, DNK, 4700
Vilacto Bio Inc is a biotech company. It operates a fully patented Lactoactive molecule for treating conditions such as inflammatory diseases, diabetics, psoriasis, and skin issues in different levels. The company is also intended to develop Lactoactive molecule for increasing the quality of its retail and medical skin cream product as well as developing products for medical applications. Its product portfolio includes lotions, skin care creams and gels, lip balms, foot creams and oils, and others.